Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) Commission File Number: 1-13595 Mettler Toledo International Inc _______________________________________________________________________________________________________________________________________ (Exact name of registrant as specified in its charter) Delaware 13-3668641 (State or other jurisdiction of (I.R.S Employer Identification No.) incorporation or organization) 1900 Polaris Parkway Colum ...

Mettler-Toledo International Inc. (NYSE:MTD) Q3 2021 Results Conference Call November 5, 2021 5:00 PM ET Company Participants Patrick Kaltenbach ??? Chief Executive Officer Shawn Vadala ??? Chief Financial Officer Mary Finnegan ??? Head of Investor Relations Conference Call Participants Eric Chung ??? Stifel Kevin Cassidy ??? Evercore Elizabeth ??? Citi Nisarg Shah ??? Nephron Research Derik De Bruin ??? Bank of America Brandon Couillard ??? Jefferies Josh Waldman ??? Cleveland Research Rachel ??? JP Morga ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) Commission File Number: 1-13595 Table of Contents Mettler Toledo International Inc _______________________________________________________________________________________________________________________________________ (Exact name of registrant as specified in its charter) Delaware 13-3668641 (State or other jurisdiction of (I.R.S Employer Identification No.) incorporation or organization) 1900 Polaris Parkway Colum ...

Earnings Webcast July 29, 2021 Mettler-Toledo International Inc. Q2 2021 Financial Results Safe Harbor Statement 2 July 29, 2021 Statements in this presentation which are not historical facts constitute "forward looking statements" within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. These statements involve known and unknown risks, uncertainties and other factors that may cause our or our businesses, actual results, levels of acti ...

Mettler-Toledo International Inc. (NYSE:MTD) Q2 2021 Earnings Conference Call July 29, 2021 5:00 PM ET Company Participants Mary Finnegan - Head of Investor Relations Patrick Kaltenbach - Chief Executive Officer Shawn Vadala - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Jack Meehan - Nephron Research Tycho Peterson - JPMorgan Derik De Bruin - Bank of America Patrick Donnelly - Citi Matt Sykes - Goldman Sachs Josh Waldman - Cleveland Research Brandon Couillard - Jefferies Operator ...

Financial Data and Key Metrics Changes - Sales for Q1 2021 were $804.4 million, an increase of 18% in local currency and 24% in USD, with currency contributing 6% to sales growth [17] - Adjusted EPS for the quarter was $6.56, a 64% increase from $4 in the prior year, with currency benefiting adjusted EPS growth by approximately 7% [25] - Gross margin improved to 58.6%, a 90 basis point increase from 57.7% in the prior year, driven by pricing, volume, and temporary cost savings [20] Business Line Data and Key Metrics Changes - Laboratory sales increased by 20%, industrial sales by 17%, with core industrial up 26% and product inspection up 5% [18] - Food retail sales grew by 13%, benefiting from improved market demand [19] - Adjusted operating profit rose to $210.7 million, a 49% increase from $141.3 million in the prior year, with adjusted operating margins increasing by 440 basis points to 26.2% [22] Market Data and Key Metrics Changes - Local currency sales increased by 14% in both the Americas and Europe, and by 29% in Asia/Rest of the World, with China seeing a remarkable 44% growth [18] - The company expects local currency sales growth for the full year 2021 to be in the range of 10% to 12%, up from previous guidance of 5% to 7% [32] Company Strategy and Development Direction - The company remains committed to its organic growth strategy, focusing on enhancing performance and maintaining a strong track record of growth [14] - The acquisition of PendoTECH is seen as a strategic move to expand in the bioprocess market, complementing existing strengths in upstream applications [52][55] - The company plans to resume its field turbo program and add sales resources in the second half of 2021 to capitalize on market opportunities [31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued market share gains and robust sales growth, despite potential challenges from supply chain disruptions and COVID-19 impacts [29][30] - The outlook for Q2 is strong, with expectations of local currency sales growth between 19% to 21% and adjusted EPS in the range of $7.50 to $7.65, reflecting a growth rate of 42% to 45% [33] Other Important Information - The company achieved a nearly 200% increase in free cash flow generation, amounting to $139 million in Q1 [26] - The effective tax rate for the quarter was 19.5%, down from 21.5% in the prior year [24] Q&A Session Summary Question: Insights on pipette shortages and pricing impact - Management acknowledged ongoing pipette shortages, particularly related to COVID-19 testing, but expects demand to decline in the second half of the year [60] - Pricing for pipettes has increased due to resin cost hikes, with expectations for continued price increases throughout the year [62] Question: Strategic priorities and capital allocation - The company emphasizes organic growth while remaining open to bolt-on acquisitions that complement its product portfolio [70] Question: Guidance and pent-up demand - The increased guidance is based on strong Q1 results and confidence in Q2, with no pent-up demand expected in the second half of the year [78] Question: Order book and industrial market recovery - The industrial business showed strong growth, particularly in China, but the order book remains challenging due to ongoing COVID-19 restrictions [82] Question: Supply chain challenges - Management is actively managing supply chain risks, including building safety stock for critical components [120] Question: Gross margin targets - The company anticipates gross margin expansion of 50 to 60 basis points for the year, with some fluctuations due to material costs and temporary cost savings returning [123]

Q1 2021 Performance Highlights - Local currency sales increased by 18%[4] - Adjusted Operating Profit increased by 49%[4] - Adjusted EPS increased by 64%[4] Sales by Geography (Q1 2021 Local Currency Sales Growth) - Americas sales increased by 14%[8] - Europe sales increased by 29%[8] - Asia/RoW sales increased by 18%[8] Sales by Product Area (Q1 2021 Local Currency Sales Growth) - Lab product sales increased by 20%[11] - Industrial product sales increased by 17%[11] - Food Retail product sales decreased by 16%[11] Q1 2021 Financial Results - Net Sales were $804390000, with local currency growth of 18%[14] - Gross Profit was $471696000, with a margin of 586%[14] - Adjusted Operating Profit was $210672000, a 49% increase[14] - Adjusted EPS was $656, a 64% increase[14]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021, OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ________________ Commission File Number: 1-13595 Mettler Toledo International Inc _________________________________________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-13595 OR Mettler-Toledo International Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorp ...

Financial Data and Key Metrics Changes - The company reported Q4 sales of $938 million, a 7% increase in local currency and an 11% increase in U.S. dollars due to currency benefits of 4% [20] - Adjusted EPS for the quarter was $9.26, a 19% increase from $7.78 in the prior year [28] - Gross margin improved to 59.6%, up 60 basis points from 59.0% in the previous year [24] - Adjusted operating profit increased by 14% to $292.8 million, with operating margins rising 80 basis points to 31.2% [26] Business Line Data and Key Metrics Changes - Laboratory sales increased by 12% in Q4, while industrial sales increased by 1% (core industrial up 5%, product inspection down 5%) [22] - For the full year, laboratory sales grew by 5%, industrial sales declined by 1%, and food retail sales decreased by 4% [23] - Service and consumables grew by 13% in Q4 and 8% for the full year [51] Market Data and Key Metrics Changes - Local currency sales growth by region in Q4: Americas up 8%, Europe up 7%, Asia (rest of the world) up 8%, and China up 12% [20] - For the full year 2020, local currency sales increased by 2% in the Americas, 1% in Europe, and 3% in Asia, with China growing by 7% [21] Company Strategy and Development Direction - The company aims to continue its organic growth strategy and enhance performance through digital transformation and sophisticated analytics [10][54] - Focus on launching new products that provide clear value to customers, with a notable upcoming launch of an automatic laboratory balance [61][62] - The company plans to maintain its pricing and productivity initiatives, leveraging analytics and machine learning for effective pricing [63] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in capturing growth as customer demand improves, despite ongoing challenges from COVID-19 [14][35] - For 2021, the company expects local currency sales growth of 5% to 7% and adjusted EPS in the range of $29.20 to $29.80, reflecting a growth rate of 14% to 16% [37] - Management acknowledged potential challenges in the second half of 2021 due to tougher comparisons and uncertainties related to COVID-19 [39][40] Other Important Information - The company reported adjusted free cash flow of $218 million in Q4, a 20% increase on a per-share basis compared to the prior year [32] - The effective tax rate for the full year was reduced from 20.5% to 19.5%, with expectations to maintain this rate in 2021 [27][41] Q&A Session Summary Question: Durability of service and consumable sales growth - Management estimated that COVID-related tailwinds contributed about 1% to 2% to the service and consumable business, which remains healthy and sustainable [71][72] Question: Product inspection demand and customer commitments - Management noted that customers are hesitant to commit to new packaging lines due to operational challenges from COVID, but expects pent-up demand to materialize in the second half of the year [74][75] Question: Growth expectations in China - Management expressed optimism about continued growth in China, projecting high single-digit growth for the full year, with mid to high 20s growth expected in Q1 [79][80] Question: Pricing realization in 2020 and expectations for 2021 - The company achieved just under 2.5% price realization in Q4, with expectations for 150 to 200 basis points in 2021 [85][87] Question: Market share gains - Management indicated confidence in gaining market share, supported by data analytics and a focus on converting non-customers [89][91] Question: Operating environment assumptions for guidance - Management assumes a relatively stable environment for guidance, with no significant improvement expected in the microenvironment [96][98]